46 results
8-K
EX-10.2
APDN
Applied Dna Sciences Inc
1 Feb 24
Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
12:00am
the Company or its Subsidiaries or their financial results or prospects.
(jj) Cybersecurity. (i)(x) There has been no security breach or other
8-K
EX-2.1
APDN
Applied Dna Sciences Inc
13 Jul 23
Entry into a Material Definitive Agreement
5:04pm
as currently conducted or as contemplated to be conducted. The Company has in-place data security and cybersecurity controls, including organizational … and cybersecurity controls, including organizational, technological and physical security measures which has not been fully addressed and remediated
8-K
EX-10.1
iblddf5 5oe4gcru1
8 Aug 22
Applied DNA Announces Pricing of $12 Million Upsized Public Offering, Priced at a Premium to Market Under Nasdaq Rules
9:55pm
424B4
0bgm62 4q3dq7w1ohw
8 Aug 22
Prospectus supplement with pricing info
8:21am
424B4
lo3pk69a1s
5 Aug 22
Prospectus supplement with pricing info
9:33pm
424B3
04ud7rd13tmal
27 Jul 22
Prospectus supplement
5:27pm
424B5
3yt962rt 964i1by
23 Feb 22
Prospectus supplement for primary offering
9:21am
8-K
EX-10.1
a9y79g6wem l82dl4q0
22 Feb 22
Applied DNA Announces Pricing of $4.2 Million Registered Direct Offering
9:43pm
424B5
vyrr8n77n8io6rvt5
13 Jan 21
Prospectus supplement for primary offering
12:00am